In the largest study yet to assess the long-term safety and efficacy of the adjustable transobturator male system (ATOMS) to treat incontinence in men following invasive prostate treatment, the ...

On Wednesday, Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC has begun manufacturing the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male ...

FREEHOLD, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision ...

The electronic device was successfully implanted and activated in 6 men with SUI who experienced reduction in pad usage over 1 year. “The results of this first in human study demonstrate that the ...

Stress urinary incontinence (SUI) is a condition that as many as 10% of men will face at some point in their lives. The good news is that for patients with this condition, many treatment options are ...

CLEVELAND, OHIO, USA, December 27, 2022 /EINPresswire.com/ -- Market Overview: Several products, such as electrical stimulation devices, vaginal slings, urinary ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global urinary incontinence treatment drugs market is estimated to be valued at US$ 4,180.6 million in 2020 and is expected to ...